Logo

PierianDx: Mark McDonough

Nov 18, 2020

PierianDx has hired Mark McDonough as CEO. McDonough, who has also joined the company's board of directors, takes over from Chairman and interim CEO Joe Boorady. The previous permanent CEO, Michael Sanderson, left PierianDx in April. McDonough previously was president and CEO of immunogenomics startup Immunis.AI. He also led CombiMatrix through that firm's 2017 acquisition by Invitae.

Breaking News
The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.